股本结构
单位：万股
| 公告日期 | 2025-08-18 | 2025-07-24 | 2025-08-28 | 2025-04-02 | 2025-04-02 | 2025-04-02 |
|---|---|---|---|---|---|---|
| 证券总股本 | 547.92 | 546.10 | 530.31 | 225.80 | 225.80 | 166.49 |
| 普通股本 | 547.92 | 546.10 | 530.31 | 225.80 | 225.80 | 166.49 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-08-15 | 2025-07-24 | 2025-06-30 | 2025-03-31 | 2025-03-21 | 2024-12-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-08-18 | 547.92 | 未披露 | 定期报告 | 2025-08-15 |
| 2025-07-24 | 546.10 | 未披露 | 定期报告 | 2025-07-24 |
| 2025-08-28 | 530.31 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Issuance of SEPA commitment shares
Issuance of ordinary shares in relation to ATM
|
2025-06-30 |
| 2025-04-02 | 225.80 | 未披露 | 定期报告 | 2025-03-31 |
| 2025-04-02 | 225.80 | 未披露 | 定期报告 | 2025-03-21 |
| 2025-04-02 | 166.49 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Issuance of ordinary shares in relation to SEPA
Issuance of SEPA Commitment Shares
Exercise of Pre-funded warrants
Exercise of RSUs
Exercise of Warrants
|
2024-12-31 |
| 2024-11-14 | 165.70 | 未披露 | 定期报告 | 2024-11-08 |
| 2024-09-20 | 150.70 | 未披露 | 定期报告 | 2024-09-20 |
| 2024-09-09 | 64.37 | 未披露 | 定期报告 | 2024-09-09 |
| 2024-08-30 | 64.62 | 未披露 |
更多>>
a reverse share split of the Company’s ordinary shares, at the ratio of 1-for-12
|
2024-08-30 |
| 2024-06-05 | 635.87 | 未披露 | 定期报告 | 2024-06-03 |
| 2024-04-04 | 600.97 | 未披露 | 定期报告 | 2024-03-27 |
| 2024-04-04 | 504.53 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Exercise of Pre-funded warrants
Issuance of ordinary shares, pre-funded warrants, and warrants net of issuance costs of $815
|
2023-12-31 |
| 2023-11-22 | 400.68 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-08-09 | 380.72 | 未披露 | 定期报告 | 2023-08-08 |
| 2023-07-18 | 198.00 | 未披露 |
更多>>
Ordinary Shares offered 380,000 shares by the company
|
2023-07-18 |
| 2023-08-09 | 168.02 | 未披露 | 定期报告 | 2023-06-30 |
| 2023-05-12 | 160.00 | 未披露 |
更多>>
Galmed Pharmaceuticals Ltd. (the “Company”) is announcing that it will effect a reverse share split of the Company’s ordinary shares at the ratio of 1-for-15, such that each fifteen (15) ordinary shares, par value NIS 0.01 per share, shall be consolidated into one (1) ordinary share, par value NIS 0.15.
|
2023-05-15 |
| 2023-03-29 | 2520.34 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of ordinary shares
|
2022-12-31 |
| 2022-05-02 | 2508.84 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Exercise of options and vesting of restricted stock units
Issuance of ordinary shares in ATM offering, net of $295 issuance costs
Issuance of ordinary shares under Underwritten Public Offering agreement, net of $786 issuance costs
|
2021-12-31 |
| 2021-03-18 | 2508.39 | 未披露 |
更多>>
1.Ordinary shares offered by the company pursuant to this prospectus supplement 2,197,803 ordinary shares.
2.The number of ordinary shares to be outstanding after this offering is based on 21,325,975 shares outstanding as of December 31, 2020.
|
2021-02-18 |
| 2021-03-18 | 2132.60 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Exercise of options and restricted stock units
Issuance of Ordinary Shares
|
2020-12-31 |
| 2020-11-12 | 2131.20 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
ATM
Exercise of options
|
2020-09-30 |
| 2020-03-12 | 2115.32 | 未披露 | 定期报告 | 2020-02-28 |
| 2020-03-12 | 2113.94 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Exercise of options and restricted stock units
|
2019-12-31 |
| 2019-11-06 | 2112.41 | 未披露 | 定期报告 | 2019-09-30 |
| 2019-08-05 | 2112.13 | 未披露 |
更多>>
from March 31, 2019 to June 30, 2019
Exercise of options and restricted stock units
|
2019-06-30 |
| 2019-05-07 | 2111.31 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Options and Restricted stock units Exercise
|
2019-03-31 |
| 2019-03-13 | 2101.89 | 未披露 |
更多>>
From December 31, 2017 to December 31, 2018
Issuance of Ordinary Shares and warrants
Exercise of options and restricted stock units
|
2018-12-31 |
| 2018-11-05 | 2100.38 | 未披露 |
更多>>
From December 31, 2017 to September 30, 2018
Options and Restricted stock units Exercise
Issuance of Ordinary Shares and warrants
Issuance of Ordinary Shares (Underwriter agreement)
Issuance of Ordinary Shares (ATM offering)
|
2018-09-30 |
| 2018-07-19 | 2091.40 | 未披露 | 定期报告 | 2018-07-15 |
| 2018-08-02 | 2091.28 | 未披露 |
更多>>
from December 31, 2017 to June 30, 2018
Options and Restricted stock units Exercise
Issuance of Ordinary Shares and warrants
Issuance of Ordinary Shares (Underwriter agreement)
Issuance of Ordinary Shares (ATM offering)
|
2018-06-30 |
| 2018-05-09 | 1447.24 | 未披露 |
更多>>
from December 31, 2017 to February 28, 2018
Options and Restricted stock units Exercise
|
2018-02-28 |
| 2018-03-13 | 1443.52 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of Ordinary Shares
Options and Restricted stock units Exercise
|
2017-12-31 |
| 2017-11-09 | 1273.35 | 未披露 |
更多>>
from December 31, 2016 to September 30, 2017
Issuance of Ordinary Shares
Options and Restricted stock units Exercise
|
2017-09-30 |
| 2017-07-31 | 1221.92 | 未披露 |
更多>>
from December 31, 2016 to June 30, 2017
Issuance of Ordinary Shares
|
2017-06-30 |
| 2017-04-27 | 1217.30 | 未披露 | 定期报告 | 2017-04-27 |
| 2017-03-23 | 1214.92 | 未披露 |
更多>>
from December 31, 2015 to September 30, 2016
Issuance of Ordinary Shares
Issuance of common stock upon stock option exercises
|
2016-09-30 |
| 2016-08-03 | 1110.28 | 未披露 | 定期报告 | 2016-06-30 |
| 2015-03-31 | 1110.05 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Reorganization and stock split
Issuance of ordinary shares in February 2014
Issuance of ordinary shares upon initial public offering, net in March 2014
Cashless exercise of options
|
2014-12-31 |
| 2014-11-06 | 1110.05 | 未披露 | 定期报告 | 2014-11-03 |
| 2014-07-25 | 1110.05 | 未披露 |
更多>>
from February 2, 2014 to June 30, 2014
Reorganization and stock split
Issuance of ordinary shares in February 2014
Issuance of ordinary shares upon initial public offering, net in March 2014
Cashless exercise of options
|
2014-06-30 |
| 2014-05-07 | 1110.05 | 未披露 | 定期报告 | 2014-05-01 |
| 2014-05-14 | 1110.05 | 未披露 |
更多>>
from February 2, 2014 to March 31, 2014
Reorganization and stock split
Issuance of ordinary shares in February 2014
Issuance of ordinary shares upon initial public offering, net in March 2014
Cashless exercise of options
|
2014-03-31 |
| 2014-03-13 | 1049.74 | 未披露 | 定期报告 | 2014-03-13 |
| 2014-02-28 | 766.00 | 未披露 | 定期报告 | 2014-02-27 |
| 2014-02-06 | 709.97 | 未披露 | 定期报告 | 2013-12-31 |
From March 31, 2025 to June 30, 2025
Issuance of SEPA commitment shares
Issuance of ordinary shares in relation to ATM
From December 31, 2023 to December 31, 2024
Issuance of ordinary shares in relation to SEPA
Issuance of SEPA Commitment Shares
Exercise of Pre-funded warrants
Exercise of RSUs
Exercise of Warrants
a reverse share split of the Company’s ordinary shares, at the ratio of 1-for-12
From December 31, 2022 to December 31, 2023
Exercise of Pre-funded warrants
Issuance of ordinary shares, pre-funded warrants, and warrants net of issuance costs of $815
Ordinary Shares offered 380,000 shares by the company
Galmed Pharmaceuticals Ltd. (the “Company”) is announcing that it will effect a reverse share split of the Company’s ordinary shares at the ratio of 1-for-15, such that each fifteen (15) ordinary shares, par value NIS 0.01 per share, shall be consolidated into one (1) ordinary share, par value NIS 0.15.
From December 31, 2021 to December 31, 2022
Issuance of ordinary shares
From December 31, 2020 to December 31, 2021
Exercise of options and vesting of restricted stock units
Issuance of ordinary shares in ATM offering, net of $295 issuance costs
Issuance of ordinary shares under Underwritten Public Offering agreement, net of $786 issuance costs
1.Ordinary shares offered by the company pursuant to this prospectus supplement 2,197,803 ordinary shares.
2.The number of ordinary shares to be outstanding after this offering is based on 21,325,975 shares outstanding as of December 31, 2020.
from December 31, 2019 to December 31, 2020
Exercise of options and restricted stock units
Issuance of Ordinary Shares
From June 30, 2020 to September 30, 2020
ATM
Exercise of options
from December 31, 2018 to December 31, 2019
Exercise of options and restricted stock units
from March 31, 2019 to June 30, 2019
Exercise of options and restricted stock units
from December 31, 2018 to March 31, 2019
Options and Restricted stock units Exercise
From December 31, 2017 to December 31, 2018
Issuance of Ordinary Shares and warrants
Exercise of options and restricted stock units
From December 31, 2017 to September 30, 2018
Options and Restricted stock units Exercise
Issuance of Ordinary Shares and warrants
Issuance of Ordinary Shares (Underwriter agreement)
Issuance of Ordinary Shares (ATM offering)
from December 31, 2017 to June 30, 2018
Options and Restricted stock units Exercise
Issuance of Ordinary Shares and warrants
Issuance of Ordinary Shares (Underwriter agreement)
Issuance of Ordinary Shares (ATM offering)
from December 31, 2017 to February 28, 2018
Options and Restricted stock units Exercise
from December 31, 2016 to December 31, 2017
Issuance of Ordinary Shares
Options and Restricted stock units Exercise
from December 31, 2016 to September 30, 2017
Issuance of Ordinary Shares
Options and Restricted stock units Exercise
from December 31, 2016 to June 30, 2017
Issuance of Ordinary Shares
from December 31, 2015 to September 30, 2016
Issuance of Ordinary Shares
Issuance of common stock upon stock option exercises
from December 31, 2013 to December 31, 2014
Reorganization and stock split
Issuance of ordinary shares in February 2014
Issuance of ordinary shares upon initial public offering, net in March 2014
Cashless exercise of options
from February 2, 2014 to June 30, 2014
Reorganization and stock split
Issuance of ordinary shares in February 2014
Issuance of ordinary shares upon initial public offering, net in March 2014
Cashless exercise of options
from February 2, 2014 to March 31, 2014
Reorganization and stock split
Issuance of ordinary shares in February 2014
Issuance of ordinary shares upon initial public offering, net in March 2014
Cashless exercise of options